Kazia Therapeutics Annual Reports 2023

78 DIRECTORS’ DECLARATION 30 June 2023 FINANCIAL REPORT In the directors’ opinion: • the attached financial statements and notes comply with the Corporations Act 2001, the Accounting Standards, the Corporations Regulations 2001 and other mandatory professional reporting requirements; • the attached financial statements and notes comply with International Financial Reporting Standards as issued by the International Accounting Standards Board as described in note 2 to the financial statements; • the attached financial statements and notes give a true and fair view of the consolidated entity’s financial position as at 30 June 2023 and of its performance for the financial year ended on that date; and • subject to the matters disclosed under Going concern in Note 2, the directors have reasonable grounds to believe that the Company will be able to pay its debts as and when they become due and payable. The directors have been given the declarations required by section 295A of the Corporations Act 2001. Signed in accordance with a resolution of directors made pursuant to section 295(5)(a) of the Corporations Act 2001. On behalf of the Board of Directors Dr John Friend Karen Krumeich Interim Chairman, Managing Director, Chief Executive Officer Chief Financial Officer 31 August 2023 Sydney

RkJQdWJsaXNoZXIy MjE2NDg3